Delgado, A.; Stewart, S.; Urroz, M.; RodrÃguez, A.; Borobia, A.M.; Akatbach-Bousaid, I.; González-Muñoz, M.; RamÃrez, E.
Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals. J. Clin. Med. 2021, 10, 4432.
https://doi.org/10.3390/jcm10194432
AMA Style
Delgado A, Stewart S, Urroz M, RodrÃguez A, Borobia AM, Akatbach-Bousaid I, González-Muñoz M, RamÃrez E.
Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals. Journal of Clinical Medicine. 2021; 10(19):4432.
https://doi.org/10.3390/jcm10194432
Chicago/Turabian Style
Delgado, Ana, Stefan Stewart, Mikel Urroz, Amelia RodrÃguez, Alberto M. Borobia, Ibtissam Akatbach-Bousaid, Miguel González-Muñoz, and Elena RamÃrez.
2021. "Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals" Journal of Clinical Medicine 10, no. 19: 4432.
https://doi.org/10.3390/jcm10194432
APA Style
Delgado, A., Stewart, S., Urroz, M., RodrÃguez, A., Borobia, A. M., Akatbach-Bousaid, I., González-Muñoz, M., & RamÃrez, E.
(2021). Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals. Journal of Clinical Medicine, 10(19), 4432.
https://doi.org/10.3390/jcm10194432